ReAHEAD: A Study to Find Out Whether Education Improves Adherence to Dabigatran in People With Atrial Fibrillation Who Are Younger Than 75 Years

CompletedOBSERVATIONAL
Enrollment

897

Participants

Timeline

Start Date

August 27, 2020

Primary Completion Date

May 8, 2023

Study Completion Date

May 8, 2023

Conditions
Atrial Fibrillation
Interventions
DRUG

Dabigatran

Dabigatran

Trial Locations (23)

106

Cathay General Hospital, Taipei

110

Taipei Medical University Hospital, Taipei

112

Cheng Hsin General Hospital, Taipei

235

Taipei Medical University-Shuang Ho Hospital, New Taipei City

300

National Taiwan University Hospital-Hsin-Chu Branch, Hsinchu

330

Chang Gung Memorial Hospital(Linkou), Taoyuan District

435

Tungs' Taichung MetroHarbor Hospital, Taichung

437

Kuang-Tien General Hospital, Taichung

622

Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi City

704

NCKUH, Tainan City

801

Kaohsiung Municipal Da-Tung Hospital, Kaohsiung City

900

Pingtung Christian Hospital, Pingtung City

970

Buddhist Tzu Chi General Hospital, Hualien City

10016

National Taiwan University Hospital, Taipei

10449

Mackay Memorial Hospital, Taipei

11217

Taipei Veterans General Hospital, Taipei

11490

Tri-Service General Hospital, Taipei

11696

Taipei Municipal Wanfang Hospital, Taipei

40705

Chia-Yi Christian Hospital, Chia-Yi City

Taichung Veterans General Hospital, Taichung

71004

Chi Mei Medical Center, Tainan City

81362

Kaohsiung Veterans General Hospital, Kaohsiung City

83301

Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT04532528 - ReAHEAD: A Study to Find Out Whether Education Improves Adherence to Dabigatran in People With Atrial Fibrillation Who Are Younger Than 75 Years | Biotech Hunter | Biotech Hunter